Communiqués Cipher Pharmaceuticals Inc.

Actions

CPH

CA17253X1050

Marché Fermé - Toronto S.E. Autres places de cotation 22:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
8,2 ^CAD	-2,96%		-3,30%	+48,01%

13/05	CIPHER PHARMACEUTICALS INC. : Stifel GMP moins optimiste	ZM
10/05	Transcript : Cipher Pharmaceuticals Inc., Q1 2024 Earnings Call, May 10, 2024

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders	17/06	AQ
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders	14/06	AQ
Cipher Pharmaceuticals : Financial Document	10/05	PU
Cipher Pharmaceuticals Reports First Quarter 2024 Results	09/05	AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	06/05	AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	03/05	AQ
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference	03/04	NE
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results	14/03	AQ
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call	08/03	AQ
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading	29/01	AQ
Cipher Pharmaceuticals Announces Change of Auditor	27/11	AQ
Cipher Pharmaceuticals Announces Change of Auditor	24/11	AQ
Cipher Pharmaceuticals Announces Normal Course Issuer Bid	15/11	AQ
Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023	09/11	AQ
Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call	30/10/23	AQ
Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call	27/10/23	AQ
Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid	12/10/23	AQ
Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer Bid	03/10/23	AQ
Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars	05/09/23	AQ
Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico	10/08/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cipher Pharmaceuticals Inc.

Actions

CPH

CA17253X1050

Communiqués

Filtres